Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 5, 2009 - Issue 3
Submit an article Journal homepage
40
Views
3
CrossRef citations to date
0
Altmetric
Review

Natural killer T cells regulate the development of asthma

Muriel Pichavant Division of Immunology and Allergy, Harvard Medical School, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA. [email protected]
,
Ponpan Matangkasombut Division of Immunology and Allergy, Harvard Medical School, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
,
Rosemarie H DeKruyff Division of Immunology and Allergy, Harvard Medical School, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
&
Dale T Umetsu Division of Immunology, Harvard Medical School, Children’s Hospital Boston, Karp Labs, Room 10127, One Blackfan Circle, Boston, MA 02115, USA. [email protected]
Pages 251-260 | Published online: 10 Jan 2014

References

  • Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol.17, 255–281 (1999).
  • Busse WW, Lemanske RF Jr. Asthma. N. Engl. J. Med.344, 350–362 (2001).
  • Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma: United States, 1980–1999. MMWR Surveill. Summ.51, 1–13 (2002).
  • Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat. Immunol.3, 715–720 (2002).
  • Gold DR, Wright R. Population disparities in asthma. Annu. Rev. Public Health26, 89–113 (2005).
  • Kiley J, Smith R, Noel P. Asthma phenotypes. Curr. Opin. Pulm. Med.13, 19–23 (2007).
  • Umetsu DT, Dekruyff RH. Immune dysregulation in asthma. Curr. Opin. Immunol.18, 727–732 (2006).
  • Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J. Exp. Med.203, 1435–1446 (2006).
  • Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest119, 1329–1336 (2001).
  • Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature454, 445–454 (2008).
  • Miyahara N, Swanson BJ, K Takeda et al. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat. Med.10, 865–869 (2004).
  • Li N, Alam J, Venkatesan MI et al. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J. Immunol.173, 3467–3481 (2004).
  • Brusasco V, Crimi E, Pellegrino R. Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax53, 992–998 (1998).
  • Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science282, 2258–2261 (1998).
  • Gillis HL, Lutchen KR. Airway remodeling in asthma amplifies heterogeneities in smooth muscle shortening causing hyperresponsiveness. J. Appl. Physiol.86, 2001–2012 (1999).
  • James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis.139, 242–246 (1989).
  • Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins: 1986. J. Immunol.175, 5–14 (2005).
  • Maggi E. The Th1/Th2 paradigm in allergy. Immunotechnology3, 233–244 (1998).
  • Romagnani S. Th1/Th2 cells. Inflamm. Bowel Dis.5, 285–294 (1999).
  • Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med.326, 298–304 (1992).
  • Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science282, 2261–2263 (1998).
  • Romagnani S. Immunologic influences on allergy and the Th1/Th2 balance. J. Allergy Clin. Immunol.113, 395–400 (2004).
  • Gavett SH, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell. Mol. Biol.10, 587–593 (1994).
  • Wills-Karp M, Ewart SL. The genetics of allergen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med.156, S89–96 (1997).
  • Martinez FD, Wright AL, Taussig LM et al. Asthma and wheezing in the first six years of life. N. Engl. J. Med.332, 133–138 (1995).
  • Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol.22, 789–815 (2004).
  • Anderson GP . Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet372, 1107–1119 (2008).
  • Cho SH, Stanciu LA, Holgate ST, Johnston SL. Increased interleukin-4, interleukin-5, and interferon-γ in airway CD4+ and CD8+ T cells in atopic asthma. Am. J. Respir. Crit. Care Med.171, 224–230 (2005).
  • Nakao F, Ihara K, Kusuhara K et al. Association of IFN-γ and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J. Allergy Clin. Immunol.107, 499–504 (2001).
  • Bullens DM, Truyen E, Coteur L et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir. Res.7, 135 (2006).
  • Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol. Int.57, 121–134 (2008).
  • Pichavant M, Goya S, Meyer EH et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med.205, 385–393 (2008).
  • Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J. Allergy Clin. Immunol.119, 1043–1052 (2007).
  • Kay AB. Inflammatory cells in bronchial asthma. J. Asthma26, 335–344 (1989).
  • Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax62, 211–218 (2007).
  • Corren J. Allergic rhinitis and asthma: how important is the link?. J. Allergy Clin. Immunol.99, S781–786 (1997).
  • Leckie M, ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet356, 2144–2148 (2000).
  • Bryan S, O’Connor B, Matti S et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet356, 2149–2153 (2000).
  • Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two Phase 2a studies. Lancet370, 1422–1431 (2007).
  • Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil’s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med.167, 199–204 (2003).
  • Hart TK, Blackburn MN, Brigham-Burke M et al. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin. Exp. Immunol.130, 93–100 (2002).
  • Holgate ST . Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease. Cytokine28, 152–157 (2004).
  • Stokes J, Casale TB. Rationale for new treatments aimed at IgE immunomodulation. Ann. Allergy Asthma Immunol.93, 212–217 (2004).
  • Holgate ST. Epithelial damage and response. Clin. Exp. Allergy30(Suppl. 1), 37–41 (2000).
  • Akbari O, Stock P, Meyer E et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med.9, 582–588 (2003).
  • Kim EY, Battaile JT, Patel AC et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med.14, 633–640 (2008).
  • Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system. Curr. Opin. Immunol.20, 358–368 (2008).
  • Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol.15, 535–562 (1997).
  • Brossay L, Chioda M, Burdin N et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med.188, 1521–1528 (1998).
  • Umetsu DT, DeKruyff RH. A role for natural killer T cells in asthma. Nat. Rev. Immunol.6, 953–958 (2006).
  • Hayakawa Y, Godfrey DI, Smyth MJ. α-galactosylceramide: potential immunomodulatory activity and future application. Curr. Med. Chem.11, 241–252 (2004).
  • Oki S, Miyake S. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. Allergol. Int.56, 7–14 (2007).
  • Joetham A, Takeda K, Taube C et al. Airway hyperresponsiveness in the absence of CD4+ T cells after primary but not secondary challenge. Am. J. Respir. Cell. Mol. Biol.33, 89–96 (2005).
  • Lisbonne M, Diem S, de Castro Keller A et al. Cutting edge: invariant V α 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol.171, 1637–1641 (2003).
  • Korsgren M, Persson CG, Sundler F et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med.189, 553–562 (1999).
  • Michel ML, Keller AC, Paget C et al. Identification of an IL-17-producing NK1.1- iNKT cell population involved in airway neutrophilia. J. Exp. Med.204, 995–1001 (2007).
  • Rachitskaya AV, Hansen AM, Horai R et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol.180, 5167–5171 (2008).
  • Hamelin ME, Prince GA, Gomez AM, Kinkead R, Boivin G. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J. Infect. Dis.193, 1634–1642 (2006).
  • Sigurs N, Gustafsson PM, Bjarnason R et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med.171, 137–141 (2005).
  • Djukanovic R, Gadola SD. Virus infection, asthma, and chronic obstructive pulmonary disease. N. Engl. J. Med.359, 2062–2064 (2008).
  • Meyer EH, Goya S, Akbari O et al. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl Acad. Sci. USA103, 2782–2787 (2006).
  • Kinjo Y, Wu D, Kim G et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature434, 520–525 (2005).
  • Kinjo Y, Tupin E, Wu D et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol.7, 978–986 (2006).
  • Mattner J, Debord KL, Ismail N et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature434, 525–529 (2005).
  • Agea E, Russano A, Bistoni O et al. Human CD1-restricted T cell recognition of lipids from pollens. J. Exp. Med.202, 295–308 (2005).
  • Spinozzi F, Porcelli SA. Recognition of lipids from pollens by CD1-restricted T cells. Immunol. Allergy Clin. North Am.27, 79–92 (2007).
  • Maeda M, Shadeo A, MacFadyen AM, Takei F. CD1d-independent NKT cells in β 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J. Immunol.172, 6115–6122 (2004).
  • Zhang Y, Rogers KH, Lewis DB. β 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med.184, 1507–1512 (1996).
  • Brown DR, Fowell DJ, Corry DB et al. β 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med.184, 1295–1304 (1996).
  • Das J, Eynott P, Jupp R et al. Natural killer T cells and CD8+ T cells are dispensable for T cell-dependent allergic airway inflammation. Nat. Med.12, 1345–1346 (2006).
  • Balk SP, Burke S, Polischuk JE et al. β 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science265, 259–262 (1994).
  • Koh YI, Kim HY, Meyer EH et al. Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in β2-microglobulin-deficient mice. J. Immunol.181, 4560–4569 (2008).
  • Shimamura M, Huang YY. Presence of a novel subset of NKT cells bearing an invariant V(α)19.1-J(α)26 TCR α chain. FEBS Lett.516, 97–100 (2002).
  • Brasier AR, Victor S, Boetticher G et al. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J. Allergy Clin. Immunol.121, 30–37.e36 (2008).
  • Hellings PW, Kasran A, Liu Z et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell. Mol. Biol.28, 42–50 (2003).
  • Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med.97, 726–733 (2003).
  • Pene J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol.180, 7423–7430 (2008).
  • Schnyder-Candrian S, Togbe D, Couillin I et al. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med.203, 2715–2725 (2006).
  • McKinley L, Alcorn JF, Peterson A et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol.181, 4089–4097 (2008).
  • Song C, Luo L, Lei Z et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol.181, 6117–6124 (2008).
  • Angkasekwinai P, Park H, Wang YH et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med.204, 1509–1517 (2007).
  • Tamachi T, Maezawa Y, Ikeda K et al. IL-25 enhances allergic airway inflammation by amplifying a Th2 cell-dependent pathway in mice. J. Allergy Clin. Immunol.118, 606–614 (2006).
  • Terashima A, Watarai H, Inoue S et al. A novel subset of mouse NKT cells bearing the IL-17 receptor β responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med.205(12), 2727–2733 (2008).
  • Bogiatzi SI, Fernandez I, Bichet JC et al. Cutting edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J. Immunol.178, 3373–3377 (2007).
  • Lee HC, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFκB. Proc. Natl Acad. Sci. USA104, 914–919 (2007).
  • Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J. Exp. Med.203, 269–273 (2006).
  • Rochman Y, Leonard WJ. Thymic stromal lymphopoietin: a new cytokine in asthma. Curr. Opin. Pharmacol.8, 249–254 (2008).
  • Nagata Y, Kamijuku H, Taniguchi M, Ziegler S, Seino K. Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function. Int. Arch. Allergy Immunol.144, 305–314 (2007).
  • Kondo Y, Yoshimoto T, Yasuda K et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol.20, 791–800 (2008).
  • Fang L, Adkins B, Deyev V, Podack ER. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med.205, 1037–1048 (2008).
  • Akbari O, Faul JL, Hoyte EG et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med.354, 1117–1129 (2006).
  • Sen Y, Yongyi B, Yuling H et al. V α 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J. Immunol.175, 4914–4926 (2005).
  • Pham-Thi N, de Blic J, Le Bourgeois M, Dy M, Scheinmann P, Leite-de-Moraes MC. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma. J. Allergy Clin. Immunol.117, 217–218 (2006).
  • Pham-Thi N, de Blic J, Leite-de-Moraes MC. Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med.354, 2613–2616; author reply 2613–2616 (2006).
  • Russano AM, Agea E, Casciari C, de Benedictis FM, Spinozzi F. Complementary roles for lipid and protein allergens in triggering innate and adaptive immune systems. Allergy63, 1428–1437 (2008).
  • Fujiki R, Yokoyama T, Watson RM, Gauvreau G, O’Byrne PM. NKT cells in sputum and peripheral blood from subjects with allergen-induced late asthmatic responses. J. Resp. Crit. Care Med.175 (2007) (Abstract A680).
  • Hamzaoui A, Rouhou SC, Grairi H et al. NKT cells in the induced sputum of severe asthmatics. Mediators Inflamm.2006(2), 1–6 (2006).
  • Yamamoto H, Okamoto Y, Horiguchi S, Kunii N, Yonekura S, Nakayama T. Detection of natural killer T cells in the sinus mucosa from asthmatics with chronic sinusitis. Allergy62, 1451–1455 (2007).
  • Vijayanand P, Seumois G, Pickard C et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med.356, 1410–1422 (2007).
  • Thomas SY, Lilly CM, Luster AD. Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med.354, 2613–2616; author reply 2613–2616 (2006).
  • Thomas SY, Banerji A, Medoff BD, Lilly CM, Luster AD. Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway. J. Immunol.179, 1901–1912 (2007).
  • Bratke K, Julius P, Virchow JC. Invariant natural killer T cells in obstructive pulmonary diseases. N. Engl. J. Med.357, 194; author reply 194–195 (2007).
  • Mutalithas K, Croudace J, Guillen C et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. J. Allergy Clin. Immunol.119, 1274–1276 (2007).
  • Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med.346, 1699–1705 (2002).
  • Matangkasombut P, Pichavant M, Yasumi T et al. Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates. J. Allergy Clin. Immunol.121, 1287–1289 (2008).
  • Coffman RL, Hessel EM. Nonhuman primate models of asthma. J. Exp. Med.201, 1875–1879 (2005).
  • Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol.117, 522–543 (2006).
  • Hachem P, Lisbonne M, Michel ML et al. α-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-γ. Eur. J. Immunol.35, 2793–2802 (2005).
  • Matsuda H, Suda T, Sato J et al. α-galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell. Mol. Biol.33, 22–31 (2005).
  • Morishima Y, Ishii Y, Kimura T et al. Suppression of eosinophilic airway inflammation by treatment with α-galactosylceramide. Eur. J. Immunol.35, 2803–2814 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.